References
- McCann JC, Ames BN. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr 2007;85:931–45.
- Ganz T. Hepcidin and the global burden of iron deficiency. Clin Chem 2015;61:577–8.
- Peters HP, Laarakkers CM, Pickkers P, et al. Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol 2013;14:70.
- Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090–3.
- Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650–69.
- Müller KF, Lorenz L, Poets CF, et al. Hepcidin concentrations in serum and urine correlate with iron homeostasis in preterm infants. J Pediatr 2012;160:949–53.
- Cherian S, Forbes DA, Cook AG, et al. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One 2008;3:e4030
- Prowle JR, Westerman M, Bellomo R. Urinary hepcidin: an inverse biomarker of acute kidney injury after cardiopulmonary bypass? Curr Opin Crit Care 2010;16:540–4.
- Altamura S, Kiss J, Blattmann C, et al. SELDI-TOF MS detection of urinary hepcidin. Biochimie 2009;91:1335–8.
- Swinkels DW, Girelli D, Laarakkers C, et al Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 2008;3:e2706
- Bansal SS, Halket JM, Fusova J, et al. Quantification of hepcidin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2009;23:1531–42.
- Bansal SS, Halket JM, Bomford A, et al. Quantitation of hepcidin in human urine by liquid chromatography-mass spectrometry. Anal Biochem 2009;384:245–53.
- Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002;277:37597–603.
- Kroot JJ, Hendriks JC, Laarakkers CM, et al. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem 2009;389:124–9.
- Mast AE, Blinder MA, Gronowski AM, et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998;44:45–51.
- Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.
- Wolff F, Deleers M, Melot C, et al. Hepcidin-25: Measurement by LC-MS/MS in serum and urine, reference ranges and urinary fractional excretion. Clin Chim Acta 2013;423:99–104.
- Hubert P, Nguyen-Huu JJ, Boulanger B, et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal–part II. J Pharm Biomed Anal 2007;45:70–81.
- Viswanathan CT, Bansal S, Booth B, et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res 2007;24:1962–73. ()
- Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood 2008;112:4292–7.
- Kemna EH, Tjalsma H, Podust VN, Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 2007;53:620–8.
- Kulaksiz H, Theilig F, Bachmann S, et al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 2005;184:361–70.
- Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. Jama 1997;277:973–6.
- Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010;139:393–408.
- Krause A, Neitz S, Mägert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147–50.
- Troutt JS, Rudling M, Persson L, et al. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration. Clin Chem 2012;58:1225–32.
- Schaap CC, Hendriks JC, Kortman GA, et al. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin Chem 2013;59:527–35.